These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 23271612)

  • 1. Valproate-induced hyperammonaemia superimposed upon severe neuropsychiatric lupus: a case report and review of the literature.
    Chan E; McQueen F
    Clin Rheumatol; 2013 Mar; 32(3):403-7. PubMed ID: 23271612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Valproate-induced hyperammonemia - uncovering an underlying inherited metabolic disorder: a case report.
    Mehta S; Tayabali S; Lachmann R
    J Med Case Rep; 2018 May; 12(1):134. PubMed ID: 29769109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lesson of the month 1: Sodium valproate-induced encephalopathy.
    Camilleri L
    Clin Med (Lond); 2018 Oct; 18(5):430-432. PubMed ID: 30287443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Valproate-induced hyperammonaemia.
    Raja M; Azzoni A
    J Clin Psychopharmacol; 2002 Dec; 22(6):631-3. PubMed ID: 12454569
    [No Abstract]   [Full Text] [Related]  

  • 5. Valproate-induced hyperammonaemic encephalopathy: review of 14 cases in the psychiatric setting.
    Dealberto MJ
    Int Clin Psychopharmacol; 2007 Nov; 22(6):330-7. PubMed ID: 17917551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-hyperammonaemia valproate-induced encephalopathy: A case report.
    Chen L; Xu Z; Huang H
    J Clin Pharm Ther; 2022 Mar; 47(3):415-419. PubMed ID: 34462930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case of valproate-induced encephalopathy.
    Hong L; Schutz J; Nance M
    Aust N Z J Psychiatry; 2012 Dec; 46(12):1200-1. PubMed ID: 22619383
    [No Abstract]   [Full Text] [Related]  

  • 8. Sudden valproate-induced hyperammonemia managed with L-carnitine in a medically healthy bipolar patient: Essential review of the literature and case report.
    Cattaneo CI; Ressico F; Valsesia R; D'Innella P; Ballabio M; Fornaro M
    Medicine (Baltimore); 2017 Sep; 96(39):e8117. PubMed ID: 28953637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Valproate-induced hyperammonemic encephalopathy. Review of cases in the psychiatric setting].
    Fassi G; Igoa A; Liste OA
    Vertex; 2008; 19(82):371-7. PubMed ID: 19424520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Valproate-related hyperammonemic encephalopathy: report of 1 case.
    Selvi Y; Annagur BB; Sayin AA; Akbaba N
    J Clin Psychopharmacol; 2014 Jun; 34(3):e1. PubMed ID: 24633004
    [No Abstract]   [Full Text] [Related]  

  • 11. The risk of asymptomatic hyperammonemia in children with idiopathic epilepsy treated with valproate: relationship to blood carnitine status.
    Hamed SA; Abdella MM
    Epilepsy Res; 2009 Sep; 86(1):32-41. PubMed ID: 19446440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperammonemia and coma without hepatic dysfunction induced by valproate therapy.
    Barrueto F; Hack JB
    Acad Emerg Med; 2001 Oct; 8(10):999-1001. PubMed ID: 11581089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe acute hyperammonemia after brief exposure to valproate.
    Eubanks AL; Aguirre B; Bourgeois JA
    Psychosomatics; 2008; 49(1):82-3. PubMed ID: 18212182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Valproic acid-associated hyperammonemic encephalopathy: a case report from the psychiatric setting.
    Kimmel RJ; Irwin SA; Meyer JM
    Int Clin Psychopharmacol; 2005 Jan; 20(1):57-8. PubMed ID: 15602119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gait instability in valproate-treated patients: Call to measure ammonia levels.
    Kipervasser S; Elger CE; Korczyn AD; Nass RD; Quesada CM; Neufeld MY
    Acta Neurol Scand; 2017 Nov; 136(5):401-406. PubMed ID: 28436001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of valproate-induced hyperammonemia.
    Stewart JT
    J Am Geriatr Soc; 2005 Jun; 53(6):1080. PubMed ID: 15935047
    [No Abstract]   [Full Text] [Related]  

  • 17. Hyperammonemia induced by interaction of valproate and quetiapine.
    Halaby A; Haddad R; Naja WJ
    Curr Drug Saf; 2013 Sep; 8(4):284-6. PubMed ID: 23962184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ammonia induced encephalopathy from valproic acid in a bipolar patient: case report.
    Elgudin L; Hall Y; Schubert D
    Int J Psychiatry Med; 2003; 33(1):91-6. PubMed ID: 12906346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Valproate-induced hyperammonemic encephalopathy: a case report.
    Shah S; Wang R; Vieux U
    J Med Case Rep; 2020 Jan; 14(1):19. PubMed ID: 31980035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fatal hyperammonemia in a patient with systemic lupus erythematosus.
    Ichikawa H; Amano T; Kawabata K; Kushiro M; Wada J; Nagake Y; Makino H
    Intern Med; 1998 Aug; 37(8):700-3. PubMed ID: 9745859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.